Sir Gregory Winter

Sir Gregory Winter is the former Master of Trinity College, a Fellow of the Royal Society and a Nobel Laureate in Chemistry.  He is best known for his research and inventions relating to therapeutic antibodies made at the Medical Research Council’s Laboratory of Molecular Biology in Cambridge.

Sir Gregory has founded three biotech companies based on his inventions: Cambridge Antibody Technology in 1989 (floated on LSE in 1997, then bought by AstraZeneca), Domantis in 2000 (bought by GSK) and Bicycle Therapeutics in 2009 (floated on NASDAQ in 2019).